Cargando…

Muscarinic M1 receptors modulate endotoxemia-induced loss of synaptic plasticity

Septic encephalopathy is associated with rapid deterioration of cortical functions. Using magnetic resonance imaging (MRI) we detected functional abnormalities in the hippocampal formation of patients with septic delirium. Hippocampal dysfunction was further investigated in an animal model for sepsi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zivkovic, Aleksandar R., Sedlaczek, Oliver, von Haken, Rebecca, Schmidt, Karsten, Brenner, Thorsten, Weigand, Markus A., Bading, Hilmar, Bengtson, C. Peter, Hofer, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632469/
https://www.ncbi.nlm.nih.gov/pubmed/26531194
http://dx.doi.org/10.1186/s40478-015-0245-8
_version_ 1782399038095622144
author Zivkovic, Aleksandar R.
Sedlaczek, Oliver
von Haken, Rebecca
Schmidt, Karsten
Brenner, Thorsten
Weigand, Markus A.
Bading, Hilmar
Bengtson, C. Peter
Hofer, Stefan
author_facet Zivkovic, Aleksandar R.
Sedlaczek, Oliver
von Haken, Rebecca
Schmidt, Karsten
Brenner, Thorsten
Weigand, Markus A.
Bading, Hilmar
Bengtson, C. Peter
Hofer, Stefan
author_sort Zivkovic, Aleksandar R.
collection PubMed
description Septic encephalopathy is associated with rapid deterioration of cortical functions. Using magnetic resonance imaging (MRI) we detected functional abnormalities in the hippocampal formation of patients with septic delirium. Hippocampal dysfunction was further investigated in an animal model for sepsis using lipopolysaccharide (LPS) injections to induce endotoxemia in rats, followed by electrophysiological recordings in brain slices. Endotoxemia induced a deficit in long term potentiation which was completely reversed by apamin, a blocker of small conductance calcium-activated potassium (SK) channels, and partly restored by treatment with physostigmine (eserine), an acetylcholinesterase inhibitor, or TBPB, a selective M1 muscarinic acetylcholine receptor agonist. These results suggest a novel role for SK channels in the etiology of endotoxemia and explain why boosting cholinergic function restores deficits in synaptic plasticity. Drugs which enhance cholinergic or M1 activity in the brain may prove beneficial in treatment of septic delirium in the intensive care unit. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-015-0245-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4632469
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46324692015-11-05 Muscarinic M1 receptors modulate endotoxemia-induced loss of synaptic plasticity Zivkovic, Aleksandar R. Sedlaczek, Oliver von Haken, Rebecca Schmidt, Karsten Brenner, Thorsten Weigand, Markus A. Bading, Hilmar Bengtson, C. Peter Hofer, Stefan Acta Neuropathol Commun Research Septic encephalopathy is associated with rapid deterioration of cortical functions. Using magnetic resonance imaging (MRI) we detected functional abnormalities in the hippocampal formation of patients with septic delirium. Hippocampal dysfunction was further investigated in an animal model for sepsis using lipopolysaccharide (LPS) injections to induce endotoxemia in rats, followed by electrophysiological recordings in brain slices. Endotoxemia induced a deficit in long term potentiation which was completely reversed by apamin, a blocker of small conductance calcium-activated potassium (SK) channels, and partly restored by treatment with physostigmine (eserine), an acetylcholinesterase inhibitor, or TBPB, a selective M1 muscarinic acetylcholine receptor agonist. These results suggest a novel role for SK channels in the etiology of endotoxemia and explain why boosting cholinergic function restores deficits in synaptic plasticity. Drugs which enhance cholinergic or M1 activity in the brain may prove beneficial in treatment of septic delirium in the intensive care unit. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-015-0245-8) contains supplementary material, which is available to authorized users. BioMed Central 2015-11-04 /pmc/articles/PMC4632469/ /pubmed/26531194 http://dx.doi.org/10.1186/s40478-015-0245-8 Text en © Zivkovic et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zivkovic, Aleksandar R.
Sedlaczek, Oliver
von Haken, Rebecca
Schmidt, Karsten
Brenner, Thorsten
Weigand, Markus A.
Bading, Hilmar
Bengtson, C. Peter
Hofer, Stefan
Muscarinic M1 receptors modulate endotoxemia-induced loss of synaptic plasticity
title Muscarinic M1 receptors modulate endotoxemia-induced loss of synaptic plasticity
title_full Muscarinic M1 receptors modulate endotoxemia-induced loss of synaptic plasticity
title_fullStr Muscarinic M1 receptors modulate endotoxemia-induced loss of synaptic plasticity
title_full_unstemmed Muscarinic M1 receptors modulate endotoxemia-induced loss of synaptic plasticity
title_short Muscarinic M1 receptors modulate endotoxemia-induced loss of synaptic plasticity
title_sort muscarinic m1 receptors modulate endotoxemia-induced loss of synaptic plasticity
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632469/
https://www.ncbi.nlm.nih.gov/pubmed/26531194
http://dx.doi.org/10.1186/s40478-015-0245-8
work_keys_str_mv AT zivkovicaleksandarr muscarinicm1receptorsmodulateendotoxemiainducedlossofsynapticplasticity
AT sedlaczekoliver muscarinicm1receptorsmodulateendotoxemiainducedlossofsynapticplasticity
AT vonhakenrebecca muscarinicm1receptorsmodulateendotoxemiainducedlossofsynapticplasticity
AT schmidtkarsten muscarinicm1receptorsmodulateendotoxemiainducedlossofsynapticplasticity
AT brennerthorsten muscarinicm1receptorsmodulateendotoxemiainducedlossofsynapticplasticity
AT weigandmarkusa muscarinicm1receptorsmodulateendotoxemiainducedlossofsynapticplasticity
AT badinghilmar muscarinicm1receptorsmodulateendotoxemiainducedlossofsynapticplasticity
AT bengtsoncpeter muscarinicm1receptorsmodulateendotoxemiainducedlossofsynapticplasticity
AT hoferstefan muscarinicm1receptorsmodulateendotoxemiainducedlossofsynapticplasticity